You are here

Novo Nordisk

Building on impressive data, Novo Nordisk maps big PhIII obesity program for blockbuster hopeful semaglutide

Endpoints

Tue, 11/21/17 - 11:28 am

Novo Nordisk cutting 185 jobs, adding another 70 in commercial revamp

Fierce Pharma

Fri, 11/10/17 - 10:16 pm

[forum discussion]RIP Novo

Cafepharma Message Boards

Thu, 11/9/17 - 11:58 am

Humira back on top of TV spending list for October, ahead of Lyrica and Victoza

Fierce Pharma

Mon, 11/6/17 - 10:12 am

Diabetes industry keeps deteriorating: Sanofi and Novo announce declining sales (Q3 2017)

GoinPharma

Sat, 11/4/17 - 08:42 am

Novo Nordisk shares slip on cautious guidance, insulin pricing concerns

Drug Delivery Business News

Wed, 11/1/17 - 10:02 am

What to expect from the rest of pharma's earnings

BioPharma Dive

Mon, 10/30/17 - 09:52 am

With FDA panel backing, Novo Nordisk prepares for semaglutide's potential launch

Fierce Biotech

Thu, 10/19/17 - 12:00 pm

Novo's experimental diabetes drug likely to compete with Trulicity

Medical Marketing and Media

Tue, 10/17/17 - 08:29 pm

FDA gives Novo Nordisk top grades for its diabetes drug semaglutide, but retinopathy remains key

Endpoints

Mon, 10/16/17 - 09:42 am

diabetic retinopathy

Novo Nordisk wins FDA nod for fast-acting mealtime insulin

Drug Delivery Business News

Sat, 09/30/17 - 10:20 am

Severe hypoglycemia multiplies death risk up to fourfold in diabetes, Novo Nordisk finds

Fierce Pharma

Fri, 09/15/17 - 11:19 am

EASD: Novo Nordisk's combo Xultophy beat rivals at cutting LDL, blood pressure

Fierce Pharma

Wed, 09/13/17 - 10:57 am

LDL cholesterol

Nordisk settles DOJ’s Victoza marketing suit for $59m

Drug Delivery Business News

Wed, 09/6/17 - 10:40 am

Novo’s Victoza, new indication to reduce CV risk

GoInPharma

Sun, 08/27/17 - 06:24 pm

cardiovascular disease

FDA clears Novo Nordisk's diabetes drug to reduce cardiovascular risk

Yahoo/Reuters

Sat, 08/26/17 - 11:56 am

Diabetes drugs must prove their value to payers, analysts say

Medical Marketing and Media

Tue, 08/22/17 - 06:48 pm

The best drug is not always a guarantee for the best financial results

GoInPharma

Wed, 08/16/17 - 09:38 pm

Novo focuses on new obesity therapy Semaglutide

GoInPharma

Tue, 08/15/17 - 09:31 am

The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results

Fierce Pharma

Thu, 08/10/17 - 06:58 pm

Bristol-Myers Squibb

Pages